Fig. 1
From: miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis
miR-124 expression is correlated with enhanced metastatic behaviour in 57 CCA clinical samples. a miR-124 levels between CCA cancerous samples (N = 57) and paracancerous samples (N = 38). b miR-124 levels between CCA primary cancerous samples with lymphnode involvement (N = 32) and without lymphnode involvement (N = 25). c miR-124 levels between CCA primary cancerous samples with distant metastasis (N = 17) and without distant metastasis (N = 40). *P <0.05